4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one

C146H147F6N15O19 — CID 157478249

IUPAC4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one
SMILESC=C1CCC(N2Cc3c(OCc4ccc(CN5CC(C)(Oc6ccccc6)C5)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(CN5CC(F)(F)C5)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(CN5CC(Oc6ccc(F)cc6)C5)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(CN5CCC(F)(F)C5)cc4)cccc3C2=O)C(=O)N1.C=C1CC[C@H](N2Cc3c(OCc4ccc(CN5CCc6ccc(F)cc6C5)cc4)cccc3C2=O)C(=O)N1.O=CO
InChIInChI=1S/C32H33N3O4.C31H30FN3O4.C31H30FN3O3.C26H27F2N3O3.C25H25F2N3O3.CH2O2/c1-22-11-16-28(30(36)33-22)35-18-27-26(31(35)37)9-6-10-29(27)38-19-24-14-12-23(13-15-24)17-34-20-32(2,21-34)39-25-7-4-3-5-8-25;1-20-5-14-28(30(36)33-20)35-18-27-26(31(35)37)3-2-4-29(27)38-19-22-8-6-21(7-9-22)15-34-16-25(17-34)39-24-12-10-23(32)11-13-24;1-20-5-12-28(30(36)33-20)35-18-27-26(31(35)37)3-2-4-29(27)38-19-22-8-6-21(7-9-22)16-34-14-13-23-10-11-25(32)15-24(23)17-34;1-17-5-10-22(24(32)29-17)31-14-21-20(25(31)33)3-2-4-23(21)34-15-19-8-6-18(7-9-19)13-30-12-11-26(27,28)16-30;1-16-5-10-21(23(31)28-16)30-12-20-19(24(30)32)3-2-4-22(20)33-13-18-8-6-17(7-9-18)11-29-14-25(26,27)15-29;2-1-3/h3-10,12-15,28H,1,11,16-21H2,2H3,(H,33,36);2-4,6-13,25,28H,1,5,14-19H2,(H,33,36);2-4,6-11,15,28H,1,5,12-14,16-19H2,(H,33,36);2-4,6-9,22H,1,5,10-16H2,(H,29,32);2-4,6-9,21H,1,5,10-15H2,(H,28,31);1H,(H,2,3)/t;;28-;;;/m..0.../s1
InChIKeyBVVSXCIRNIRRGO-NISCQAPPSA-N
MW2529.86 g/mol
LogP20.81
Rot. Bonds34

About 4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one

4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one (PubChem CID 157478249) has the molecular formula C146H147F6N15O19 and a molecular weight of 2529.86 g/mol. Its IUPAC name is 4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one.

Molecular Properties

Compound Name4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one
PubChem CID157478249
Molecular FormulaC146H147F6N15O19
Molecular Weight2529.86 g/mol
Exact Mass2528.09
IUPAC Name4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one
SMILESC=C1CCC(N2Cc3c(OCc4ccc(CN5CC(C)(Oc6ccccc6)C5)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(CN5CC(F)(F)C5)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(CN5CC(Oc6ccc(F)cc6)C5)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(CN5CCC(F)(F)C5)cc4)cccc3C2=O)C(=O)N1.C=C1CC[C@H](N2Cc3c(OCc4ccc(CN5CCc6ccc(F)cc6C5)cc4)cccc3C2=O)C(=O)N1.O=CO
InChIInChI=1S/C32H33N3O4.C31H30FN3O4.C31H30FN3O3.C26H27F2N3O3.C25H25F2N3O3.CH2O2/c1-22-11-16-28(30(36)33-22)35-18-27-26(31(35)37)9-6-10-29(27)38-19-24-14-12-23(13-15-24)17-34-20-32(2,21-34)39-25-7-4-3-5-8-25;1-20-5-14-28(30(36)33-20)35-18-27-26(31(35)37)3-2-4-29(27)38-19-22-8-6-21(7-9-22)15-34-16-25(17-34)39-24-12-10-23(32)11-13-24;1-20-5-12-28(30(36)33-20)35-18-27-26(31(35)37)3-2-4-29(27)38-19-22-8-6-21(7-9-22)16-34-14-13-23-10-11-25(32)15-24(23)17-34;1-17-5-10-22(24(32)29-17)31-14-21-20(25(31)33)3-2-4-23(21)34-15-19-8-6-18(7-9-19)13-30-12-11-26(27,28)16-30;1-16-5-10-21(23(31)28-16)30-12-20-19(24(30)32)3-2-4-22(20)33-13-18-8-6-17(7-9-18)11-29-14-25(26,27)15-29;2-1-3/h3-10,12-15,28H,1,11,16-21H2,2H3,(H,33,36);2-4,6-13,25,28H,1,5,14-19H2,(H,33,36);2-4,6-11,15,28H,1,5,12-14,16-19H2,(H,33,36);2-4,6-9,22H,1,5,10-16H2,(H,29,32);2-4,6-9,21H,1,5,10-15H2,(H,28,31);1H,(H,2,3)/t;;28-;;;/m..0.../s1
InChIKeyBVVSXCIRNIRRGO-NISCQAPPSA-N
XLogP20.81
TPSA365.16 Ų
H-Bond Donors6
H-Bond Acceptors23
Rotatable Bonds34
Heavy Atoms186
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002529.86
LogP ≤ 520.81
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze 4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one?
The IUPAC name of 4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one (CID 157478249) is 4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one.
What is the SMILES notation for 4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one?
The canonical SMILES for 4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one is C=C1CCC(N2Cc3c(OCc4ccc(CN5CC(C)(Oc6ccccc6)C5)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(CN5CC(F)(F)C5)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(CN5CC(Oc6ccc(F)cc6)C5)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(CN5CCC(F)(F)C5)cc4)cccc3C2=O)C(=O)N1.C=C1CC[C@H](N2Cc3c(OCc4ccc(CN5CCc6ccc(F)cc6C5)cc4)cccc3C2=O)C(=O)N1.O=CO.
What is the InChIKey of 4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one?
The InChIKey is BVVSXCIRNIRRGO-NISCQAPPSA-N. The full InChI is InChI=1S/C32H33N3O4.C31H30FN3O4.C31H30FN3O3.C26H27F2N3O3.C25H25F2N3O3.CH2O2/c1-22-11-16-28(30(36)33-22)35-18-27-26(31(35)37)9-6-10-29(27)38-19-24-14-12-23(13-15-24)17-34-20-32(2,21-34)39-25-7-4-3-5-8-25;1-20-5-14-28(30(36)33-20)35-18-27-26(31(35)37)3-2-4-29(27)38-19-22-8-6-21(7-9-22)15-34-16-25(17-34)39-24-12-10-23(32)11-13-24;1-20-5-12-28(30(36)33-20)35-18-27-26(31(35)37)3-2-4-29(27)38-19-22-8-6-21(7-9-22)16-34-14-13-23-10-11-25(32)15-24(23)17-34;1-17-5-10-22(24(32)29-17)31-14-21-20(25(31)33)3-2-4-23(21)34-15-19-8-6-18(7-9-19)13-30-12-11-26(27,28)16-30;1-16-5-10-21(23(31)28-16)30-12-20-19(24(30)32)3-2-4-22(20)33-13-18-8-6-17(7-9-18)11-29-14-25(26,27)15-29;2-1-3/h3-10,12-15,28H,1,11,16-21H2,2H3,(H,33,36);2-4,6-13,25,28H,1,5,14-19H2,(H,33,36);2-4,6-11,15,28H,1,5,12-14,16-19H2,(H,33,36);2-4,6-9,22H,1,5,10-16H2,(H,29,32);2-4,6-9,21H,1,5,10-15H2,(H,28,31);1H,(H,2,3)/t;;28-;;;/m..0.../s1.
What are the key properties of 4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one?
4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one has a molecular weight of 2529.86 g/mol, XLogP of 20.81, 34 rotatable bonds, 6 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-[(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;4-[[4-[[3-(4-fluorophenoxy)azetidin-1-yl]methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;formic acid;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(3-methyl-3-phenoxyazetidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one is sourced from PubChem (CID 157478249), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).